- Home
- CMTL vs ANVS Comparison
CMTL vs ANVS Comparison
Compare CMTL & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMTL | ANVS |
|---|---|---|
| Founded | 1967 | 2008 |
| Country | United States | United States |
| Employees | 1385 | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.1M | 111.3M |
| IPO Year | 2024 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CMTL | ANVS |
|---|---|---|
| Price | $5.10 | $2.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $6.00 | ★ $13.50 |
| AVG Volume (30 Days) | 218.3K | ★ 306.4K |
| Earning Date | 03-16-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.92 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $499,528,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.97 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.19 | $1.11 |
| 52 Week High | $6.21 | $5.50 |
Technical Indicators
Market Signals| Indicator | CMTL | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 44.45 | 43.60 |
| Support Level | $4.86 | $2.27 |
| Resistance Level | $6.15 | $2.63 |
| Average True Range (ATR) | 0.33 | 0.20 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 25.56 | 21.54 |
Price Performance
Historical ComparisonAbout CMTL Comtech Telecommunications Corp.
Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.